Suppr超能文献

基于人群的癌症生存估计值因追溯死亡证明通知而减少:实证说明。

Reduction of population-based cancer survival estimates by trace back of death certificate notifications: an empirical illustration.

机构信息

Saarland Cancer Registry, Präsident Baltz-Straße 5, 66119 Saarbrücken, Germany.

出版信息

Eur J Cancer. 2012 Apr;48(6):797-804. doi: 10.1016/j.ejca.2011.05.028. Epub 2011 Jun 22.

Abstract

BACKGROUND

Survival studies using data from population-based cancer registries allow assessing effectiveness of cancer care on a population level. However, population-based cancer registries differ in the proportion of cases first notified by death certificate, as well as in the efforts to trace back such death certificate notifications (DCN). We aimed to assess the impact of such trace back on population-based cancer survival estimates.

MATERIALS AND METHODS

In this study from the population-based Saarland Cancer Registry (Germany) we investigated the survival experience of successfully traced back DCN cases from 1994 to 2003. Five-year relative survival of patients with DCN cancers and the effect of trace back on population-based 5-year relative survival estimates were analysed by age and tumour site.

RESULTS

Twelve percent of all cancers were DCN and such cases occurred most often amongst sites with poor prognosis and amongst elderly patients. Approximately half of DCN cases could be successfully traced back. Five-year relative survival of patients with DCN cancers with trace back was 2%. The inclusion of DCN cancers with additional registrations reduced the 5-year relative survival estimate for all cancers combined by 4% points. Reductions were stronger for older patients and highly fatal cancers.

CONCLUSIONS

Trace back results in increased inclusion of patients with very poor prognosis. Varying extent of trace back across registries may compromise comparability of cancer survival estimates and should be taken into account in comparative cancer survival studies.

摘要

背景

利用基于人群的癌症登记处的数据进行生存研究,可以在人群水平上评估癌症治疗的效果。然而,基于人群的癌症登记处之间在首次通过死亡证明通知的病例比例以及追查此类死亡证明通知(DCN)的努力方面存在差异。我们旨在评估这种追溯对基于人群的癌症生存估计的影响。

材料和方法

在这项来自基于人群的萨尔兰癌症登记处(德国)的研究中,我们调查了成功追踪到 1994 年至 2003 年的 DCN 病例的生存经验。通过年龄和肿瘤部位分析 DCN 癌症患者的 5 年相对生存率以及追溯对基于人群的 5 年相对生存率估计的影响。

结果

所有癌症的 12%是 DCN,此类病例最常发生在预后不良和老年患者的部位。大约一半的 DCN 病例可以成功追踪。有追溯的 DCN 癌症患者的 5 年相对生存率为 2%。将具有额外登记的 DCN 癌症纳入后,所有癌症的 5 年相对生存率估计值降低了 4 个百分点。对于老年患者和高致命性癌症,降幅更大。

结论

追溯导致预后极差的患者的纳入率增加。不同的登记处之间的追溯程度可能会影响癌症生存估计的可比性,在比较癌症生存研究中应考虑到这一点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验